Kremers and Urdang's History of Pharmacy

Kremers and Urdang's History of Pharmacy
Author :
Publisher : Amer. Inst. History of Pharmacy
Total Pages : 596
Release :
ISBN-10 : 0931292174
ISBN-13 : 9780931292170
Rating : 4/5 (74 Downloads)

Synopsis Kremers and Urdang's History of Pharmacy by : Edward Kremers

Bad Pharma

Bad Pharma
Author :
Publisher : Macmillan
Total Pages : 479
Release :
ISBN-10 : 9780865478060
ISBN-13 : 0865478066
Rating : 4/5 (60 Downloads)

Synopsis Bad Pharma by : Ben Goldacre

Originally published in 2012, revised edition published in 2013, by Fourth Estate, Great Britain; Published in the United States in 2012, revised edition also, by Faber and Faber, Inc.

Pharmaceutical Record

Pharmaceutical Record
Author :
Publisher :
Total Pages : 434
Release :
ISBN-10 : OSU:32435030268825
ISBN-13 :
Rating : 4/5 (25 Downloads)

Synopsis Pharmaceutical Record by :

Registries for Evaluating Patient Outcomes

Registries for Evaluating Patient Outcomes
Author :
Publisher : Government Printing Office
Total Pages : 385
Release :
ISBN-10 : 9781587634338
ISBN-13 : 1587634333
Rating : 4/5 (38 Downloads)

Synopsis Registries for Evaluating Patient Outcomes by : Agency for Healthcare Research and Quality/AHRQ

This User’s Guide is intended to support the design, implementation, analysis, interpretation, and quality evaluation of registries created to increase understanding of patient outcomes. For the purposes of this guide, a patient registry is an organized system that uses observational study methods to collect uniform data (clinical and other) to evaluate specified outcomes for a population defined by a particular disease, condition, or exposure, and that serves one or more predetermined scientific, clinical, or policy purposes. A registry database is a file (or files) derived from the registry. Although registries can serve many purposes, this guide focuses on registries created for one or more of the following purposes: to describe the natural history of disease, to determine clinical effectiveness or cost-effectiveness of health care products and services, to measure or monitor safety and harm, and/or to measure quality of care. Registries are classified according to how their populations are defined. For example, product registries include patients who have been exposed to biopharmaceutical products or medical devices. Health services registries consist of patients who have had a common procedure, clinical encounter, or hospitalization. Disease or condition registries are defined by patients having the same diagnosis, such as cystic fibrosis or heart failure. The User’s Guide was created by researchers affiliated with AHRQ’s Effective Health Care Program, particularly those who participated in AHRQ’s DEcIDE (Developing Evidence to Inform Decisions About Effectiveness) program. Chapters were subject to multiple internal and external independent reviews.

History of Drug Containers and Their Labels

History of Drug Containers and Their Labels
Author :
Publisher : Amer. Inst. History of Pharmacy
Total Pages : 164
Release :
ISBN-10 : 0931292263
ISBN-13 : 9780931292262
Rating : 4/5 (63 Downloads)

Synopsis History of Drug Containers and Their Labels by : George B. Griffenhagen

Pharmaceutical Calculations

Pharmaceutical Calculations
Author :
Publisher :
Total Pages : 428
Release :
ISBN-10 : 0812110072
ISBN-13 : 9780812110074
Rating : 4/5 (72 Downloads)

Synopsis Pharmaceutical Calculations by : Mitchell J. Stoklosa

Pharma

Pharma
Author :
Publisher : Simon and Schuster
Total Pages : 816
Release :
ISBN-10 : 9781501152047
ISBN-13 : 1501152041
Rating : 4/5 (47 Downloads)

Synopsis Pharma by : Gerald Posner

Award-winning journalist and New York Times bestselling author Gerald Posner reveals the heroes and villains of the trillion-dollar-a-year pharmaceutical industry and delivers “a withering and encyclopedic indictment of a drug industry that often seems to prioritize profits over patients (The New York Times Book Review). Pharmaceutical breakthroughs such as anti­biotics and vaccines rank among some of the greatest advancements in human history. Yet exorbitant prices for life-saving drugs, safety recalls affecting tens of millions of Americans, and soaring rates of addiction and overdose on pre­scription opioids have caused many to lose faith in drug companies. Now, Americans are demanding a national reckoning with a monolithic industry. “Gerald’s dogged reporting, sets Pharma apart from all books on this subject” (The Washington Standard) as we are introduced to brilliant scientists, incorruptible government regulators, and brave whistleblowers facing off against company exec­utives often blinded by greed. A business that profits from treating ills can create far deadlier problems than it cures. Addictive products are part of the industry’s DNA, from the days when corner drugstores sold morphine, heroin, and cocaine, to the past two decades of dangerously overprescribed opioids. Pharma also uncovers the real story of the Sacklers, the family that became one of America’s wealthiest from the success of OxyContin, their blockbuster narcotic painkiller at the center of the opioid crisis. Relying on thousands of pages of government and corporate archives, dozens of hours of interviews with insiders, and previously classified FBI files, Posner exposes the secrets of the Sacklers’ rise to power—revelations that have long been buried under a byzantine web of interlocking companies with ever-changing names and hidden owners. The unexpected twists and turns of the Sackler family saga are told against the startling chronicle of a powerful industry that sits at the intersection of public health and profits. “Explosively, even addictively, readable” (Booklist, starred review), Pharma reveals how and why American drug com­panies have put earnings ahead of patients.